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httpIntroduction: A case is reported of left brachiocephalic vein thrombus removal using the Angiovac device within a
stented venous segment via a through-and-through access technique.
Report: This novel technique involves obtaining through-and-through access from the left basilic vein to the right
femoral vein, which then facilitates the advancement of the Angiovac device to successfully remove in a stepwise
fashion the thrombus present within a stented region of the left brachiocephalic vein.
Discussion: The Angiovac device has been shown to be very useful and effective at removing large amounts of
thrombus, tumor, and foreign bodies within arterial and venous systems successfully. This novel technique uses
the through-and-through venous access approach to allow for this device to remain close to the targeted area of
thrombus burden and prevent damage of the already existing stents in this region.
 2016 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Thrombus within stented vascular segmentSince its Food and Drug Administration (FDA) approval in
2009 for removal of soft thrombus or embolic material, the
AngioVac cannula (AngioDynamics, Lathan, NY, USA) has
been successfully used in the United States with multiple
case series and reports available in the literature.1e3 The
versatility of this device has helped broaden the indications
to include cardiac vegetations, tumor thrombus, and foreign
body extractions.4e6 However, its main indication continues
to be the removal of right atrial, saddle pulmonary and
iliocaval emboli.7e9 A novel technique is described of left
brachiocephalic vein thrombus suction by using a through-
and-through venous access in a stented segment of this
vessel in an acutely symptomatic patient with left neck,
chest, and breast edema.CASE REPORT
A 50-year old female patient with a history of superior vena
cava (SVC) syndrome and previously stented SVC using a
kissing stent technique presented to the institution for the
second time with symptomatic left brachiocephalic veinrresponding author. Section of Vascular and Endovascular Surgery,
niversity School of Medicine, 330 Cedar Street, BB204, New Haven,
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://dx.doi.org/10.1016/j.ejvssr.2016.07.002stent thrombosis while on subtherapeutic (INR 1.5) anti-
coagulation (Fig. 1). The distal one-third of the stent in the
left brachiocephalic vein was patent and allowed for venous
drainage through multiple tributaries as demonstrated in
the ﬁgure. Although drainage was provided through these
tributaries, the patient was admitted after 48 hours of
acutely developing edema of the left neck, chest, and
breast. The patient was started on a heparin infusion upon
admission and prepared for mechanical thromboembolec-
tomy using the AngioVac device.
TECHNIQUE
The operative intervention was performed under general
anesthesia and systemic heparinization to an activated clot-
ting time (ACT) > 300 ms. Owing to known potential difﬁ-
culties cannulating the occluded kissing stent in the SVC
through a femoral vein approach and a patent distal left
brachiocephalic vein stent, access was initially obtained
through the left basilic vein. This initial approach assured us
that the angled-glidewire (Terumo, Somerset, NJ, USA)
remained within the lumen of the stents and not either
outside of the stents or through the stent-struts. Once within
the stents, the glidewire easily traversed the acute thrombus
of the stented area and was then maneuvered to the inferior
vena cava. This wire was then retrieved through the right
femoral vein using an Ensnare (MeritMedical, South Jordan,
UT, USA), thus obtaining through-and-through venous access
from the left basilic vein to the right femoral vein.
Figure 1. Venogram demonstrating occluded left brachiocephalic
vein stent (white arrow) and kissing stents in the superior vena
cava (black arrow).
Figure 3. Photograph of the ﬁlter reservoir from the AngioVac
system demonstrating small pieces of thrombi.
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vein over the glidewire and advanced to the area proximal
of the kissing stents in the SVC. Then, a 10 mm in diameter
by 20 mm in length balloon was used to sequentially “rake-
in” the thrombus proximally towards the AngioVac device
(Fig. 2), which was concurrently suctioning the venous
drainage and thrombus through the extracorporeal circuit.
All thrombus pieces were caught in the ﬁlter reservoir of
the AngioVac system (Fig. 3). After several passes with the
balloon, venography demonstrated stenosis of the left
brachiocephalic vein stent, which was angioplastied with an
excellent venographic end result (Fig. 4).
The patient demonstrated improvement of her symp-
toms within the ﬁrst 24 hours after the procedure; the left
neck, chest, and breast edema had all resolved. She will
remain on anticoagulation therapy to prevent re-
thrombosis of the stents. At the 3-month ultrasound
follow-up, all stents were patent. This procedure may be
required to be repeated as long term durability is unknown.
DISCUSSION
This is the ﬁrst documented case in which this device has
been used to successfully retrieve thrombus within a
stented region via a through-and-through venous access to
maintain intraluminal position of the balloon performingFigure 2. Actual “raking-in” of the thrombus burden towards the Anthe “raking-in” of the thrombus within the stented region of
the vessel.
It is understood that there could be questionable dura-
bility of the current procedure when this patient presented
to the institutions on her second episode of stent throm-
bosis. The ﬁrst event was presumed to be due to subther-
apeutic anticoagulation treatment. Therefore, during the
current hospitalization, the patient underwent a hemato-
logic consultation for a possible pro-thrombotic state and
further cardiac surgery consultation for counseling
regarding the necessity of a future open procedure togioVac device (white arrow) using a 10 mm  20 mm balloon.
Figure 4. Venogram before and after angioplasty of the left brachiocephalic vein stent.
Removal Of Brachiocephalic Vein Thrombus 23patch/bypass the stenotic/stented area. However, with the
myriad possibilities and continued progress/advancement
in the endovascular world, the AngioVac device proved to
be safe and feasible in the treatment of this patient. If
recurrence should occur, the open option will be revisited,
especially in light of the patient’s young age.
The AngioVac device has clearly demonstrated safety and
effectiveness at removing all sorts of foreign material within
the arterial and venous system (thrombus, tumor, ﬁl-
ters).2,4e6 The currently presented novel technique, dem-
onstrates its safety within thrombosed stented vascular
regions with an excellent immediate venographic and clin-
ical outcome.
CONCLUSION
This novel technique uses the through-and-through venous
access approach to allow for this device to remain close to
the targeted area of thrombus burden and prevent damage
of the already existing stents in this region.
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